| Record no |
201108059011 |
| Activity status |
Active |
| Working Title |
ANTITUBERCULAR AGENTS |
| Working Inventors |
DHIMAN SARKAR;SAMPA SARKAR;ROHIT RAMESH JOSHI;VIJAY MURLIDHAR KHEDKAR;RAGHUVIR RAMAKANT PISSURLENKAR;EVANS CLIFFTON COUTINHO;ANAMIK KANTILAL SHAH; |
| Contributing institutions |
NCL |
| Administered by |
|
| Ownership |
|
| Categories > Subjects |
Biological sciences and engineering |
| Categories > Portfolio |
Medical biotechnology/bioprocess engineering |
| Disclosure number |
2009-INV-0026 |
| NCL No |
2009-NCL-0020 |
| CSIR No |
2009-NF-0184
|
| Priority date |
05-31-2010 |
| Country |
WO |
| Application number |
PCT/IB2011/001184 |
| Provisional filing date |
|
| Complete filing date |
05-31-2011 |
| Publication status |
Yes |
| Publication date |
12-08-2011 |
| Publication no |
WO2011151701 A1 |
| Granted number |
|
| Granted date |
|
| Final title |
ANTITUBERCULAR AGENTS |
| Final Inventors |
DHIMAN SARKAR;SAMPA SARKAR;ROHIT RAMESH JOSHI;VIJAY MURLIDHAR KHEDKAR;RAGHUVIR RAMAKANT PISSURLENKAR;EVANS CLIFFTON COUTINHO;ANAMIK KANTILAL SHAH; |
| Abstract |
The present invention discloses antitubercular compounds selected from tetrahydropyrimidones tetrahydrothiopyrimidone derivatives of Formula 1 and its pharmaceutically acceptable salts for the treatment of Mycobacterium in the dormant phase. Formula 1 whe |
| Case status |
Complete specification filed |
| Licensing status |
|
| Licensing case no |
|
| Client name |
|
| Lead inventors |
SARKAR DHIMAN |
| Categories > Industry > Primary |
Medical Biotechnology,Biomed Products,Medical/Healthcare |
| Categories > Industry > other |
|